Folks, I just posted my sentiments about today on
Post# of 56324

Focus on what happened today and I am not talking about the share price. Creative's new BOD's Chairman J. Germinario made a statement in his first company PR and named Dr. David Felten to the board.
Now, look at Felten's background , really pay attention. This is another guy that should be way too qualified to be on a Pink's BOD. This is a guy that would make sense being on the BOD of a medium sized NASDAQ listed pharma company not a Pink Sheet spec play. For those of you that are newer investors, let me tell you this just never happens. Be careful with you money, but this one is quickly developing into a unique animal.

